T1	CHEM 91 98	Actemra
#1	AnnotatorNotes T1	C2740854; Actemra; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T2	CHEM 99 108	RoActemra
#2	AnnotatorNotes T2	C3272237; Roactemra; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	DISO 122 159	artritis idiopática juvenil sistémica
#3	AnnotatorNotes T3	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T4	PROC 181 223	ESTUDIO DE FASE Ib, MULTICÉNTRICO, ABIERTO
T5	CHEM 291 302	TOCILIZUMAB
#4	AnnotatorNotes T5	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 350 387	ARTRITIS IDIOPÁTICA JUVENIL SISTÉMICA
#5	AnnotatorNotes T6	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T7	DISO 420 424	AIJS
#6	AnnotatorNotes T7	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T8	DISO 432 440	artritis
#7	AnnotatorNotes T8	C0003864; Arthritis; Disease or Syndrome
T9	DISO 451 457	fiebre
#8	AnnotatorNotes T9	C0015967; Fever; Sign or Symptom
T10	DISO 469 473	rash
#9	AnnotatorNotes T10	C0015230; Exanthema; Sign or Symptom
T11	DISO 485 531	inflamación de la mucosa de pulmones o corazón
T12	ANAT 524 531	corazón
#10	AnnotatorNotes T12	C0018787; Heart; Body Part, Organ, or Organ Component | C1281570; Entire heart; Body Part, Organ, or Organ Component
T13	DISO 533 564	agrandamiento del hígado o bazo
#11	AnnotatorNotes T13	C1112137; Liver and spleen enlargement; Finding
T14	ANAT 560 564	bazo
#12	AnnotatorNotes T14	C0037993; Spleen; Body Part, Organ, or Organ Component | C1278932; Entire spleen; Body Part, Organ, or Organ Component
T15	DISO 568 607	agrandamiento de los nodulos linfáticos
T16	ANAT 589 607	nodulos linfáticos
#13	AnnotatorNotes T16	C0024204; lymph nodes; Body Part, Organ, or Organ Component | C1269047; Entire lymph node; Body Part, Organ, or Organ Component
T17	DISO 633 670	Artritis idiopatica Juvenil Sistemica
#14	AnnotatorNotes T17	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T18	DISO 672 676	AIJS
#15	AnnotatorNotes T18	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T19	PROC 776 785	screening
#16	AnnotatorNotes T19	C0220908; Screening procedure; Diagnostic Procedure
T20	DISO 788 792	AIJS
#17	AnnotatorNotes T20	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T21	PROC 793 806	diagnosticada
#18	AnnotatorNotes T21	C0011900; Diagnosis; Diagnostic Procedure
T22	PROC 913 924	tratamiento
#19	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	PROC 931 942	tratamiento
#20	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	CHEM 954 959	AINEs
#21	AnnotatorNotes T24	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T25	CHEM 962 978	corticosteroides
#22	AnnotatorNotes T25	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T26	PROC 982 1006	Tratamiento concomitante
#23	AnnotatorNotes T26	C1707479; Concomitant Therapy; Therapeutic or Preventive Procedure
T27	CHEM 1011 1017	DMARDs
T28	CHEM 1028 1031	MTX
#24	AnnotatorNotes T28	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T29	CHEM 1033 1038	AINEs
#25	AnnotatorNotes T29	C0003211; Anti-Inflammatory Agents, Non-Steroidal; Pharmacologic Substance
T30	CHEM 1042 1058	corticosteroides
#26	AnnotatorNotes T30	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T31	PROC 1110 1138	Interrupción del tratamiento
#27	AnnotatorNotes T31	C0850893; stop medication; Therapeutic or Preventive Procedure
T32	PROC 1229 1240	tratamiento
#28	AnnotatorNotes T32	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	CHEM 1256 1272	agente biologico
#29	AnnotatorNotes T33	C0005515; Biological Factors; Biologically Active Substance
T34	PROC 1382 1405	métodos anticonceptivos
#30	AnnotatorNotes T34	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T35	PROC 1433 1442	protocolo
#31	AnnotatorNotes T35	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T36	CHEM 1510 1513	TCZ
#32	AnnotatorNotes T36	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T37	PROC 1470 1498	Suspensión de un tratamiento
#33	AnnotatorNotes T37	C0850893; stop medication; Therapeutic or Preventive Procedure
T38	DISO 1557 1579	problemas de seguridad
T39	DISO 1592 1623	reacciones de hipersensibilidad
#34	AnnotatorNotes T39	C0020517; Hypersensitivity; Pathologic Function
T40	DISO 1626 1636	Enfermedad
#35	AnnotatorNotes T40	C0012634; Disease; Disease or Syndrome
T41	PROC 1706 1717	tratamiento
#36	AnnotatorNotes T41	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T42	PROC 1731 1742	tratamiento
#37	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T43	DISO 1761 1765	AIJS
#38	AnnotatorNotes T43	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T44	CHEM 1796 1814	agente terapéutico
T45	CHEM 1831 1834	TCZ
#39	AnnotatorNotes T45	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T46	DISO 1889 1895	fiebre
#40	AnnotatorNotes T46	C0015967; Fever; Sign or Symptom
T47	DISO 1929 1938	encamados
#41	AnnotatorNotes T47	C0741453; Bedridden; Finding
T48	DISO 1965 1986	enfermedad autoinmune
#42	AnnotatorNotes T48	C0004364; Autoimmune Diseases; Disease or Syndrome
T49	DISO 1988 1997	reumática
#43	AnnotatorNotes T49	C0035435; Rheumatism; Disease or Syndrome
T50	DISO 2000 2025	síndrome de superposición
#44	AnnotatorNotes T50	C0409999; Undifferentiated Connective Tissue Diseases; Disease or Syndrome
T51	DISO 2039 2043	AIJS
#45	AnnotatorNotes T51	C1384600; Systemic onset juvenile chronic arthritis; Disease or Syndrome
T52	PROC 230 287	INVESTIGAR LA FARMACOCINÉTICA, FARMACODINAMIA Y SEGURIDAD
T53	PROC 308 333	ADMINISTRACIÓN SUBCUTÁNEA
T54	ANAT 503 509	mucosa
#46	AnnotatorNotes T54	C0026724; Mucous Membrane; Tissue | C1284117; Entire mucous membrane; Tissue
T55	ANAT 513 521	pulmones
#47	AnnotatorNotes T55	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T56	ANAT 551 557	hígado
#48	AnnotatorNotes T56	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T57	CHEM 1143 1161	agentes biologicos
#49	AnnotatorNotes T57	C0005515; Biological Factors; Biologically Active Substance
T58	CHEM 1176 1179	TCZ
#50	AnnotatorNotes T58	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T59	CHEM 1754 1757	TCZ
#51	AnnotatorNotes T59	C1609165; tocilizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T60	Date 12 16	2012
T61	Route 77 87	subcutánea
#52	AnnotatorNotes T61	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T62	LIVB 112 117	niños
#53	AnnotatorNotes T62	C0008059; Child; Age Group
T63	PHYS 244 259	FARMACOCINÉTICA
#54	AnnotatorNotes T63	C0031327; Drug Kinetics; Physiologic Function
T64	Route 323 333	SUBCUTÁNEA
#55	AnnotatorNotes T64	C1522438; Subcutaneous Route of Drug Administration; Functional Concept
T65	LIVB 336 345	PACIENTES
#56	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T66	LIVB 410 415	Niños
#57	AnnotatorNotes T66	C0008059; Child; Age Group
T67	Frequency 458 464	diaria
T69	Route 1059 1065	orales
#58	AnnotatorNotes T69	C1527415; Oral Route of Drug administration; Functional Concept
T70	LIVB 1094 1106	investigador
#59	AnnotatorNotes T70	C0035173; Research Personnel; Professional or Occupational Group
T71	Route 1180 1182	IV
#60	AnnotatorNotes T71	C1522726; Intravenous Route of Drug Administration; Functional Concept
T72	Duration 1187 1193	4 días
T73	Duration 1196 1206	20 semanas
T74	LIVB 1279 1301	mujeres en edad fértil
#61	AnnotatorNotes T74	C4324275; Woman of childbearing potential; Population Group
T75	Age 1290 1301	edad fértil
T76	LIVB 1308 1315	varones
#62	AnnotatorNotes T76	C0025266; Male population group; Population Group
T77	LIVB 1320 1335	pareja femenina
#63	AnnotatorNotes T77	C0682323; Partner in relationship; Family Group + C0043210; Woman; Population Group
T78	Age 1339 1350	edad fértil
T81	Route 1514 1516	IV
#64	AnnotatorNotes T81	C1522726; Intravenous Route of Drug Administration; Functional Concept
T82	Date 1743 1749	actual
T83	Route 1758 1760	IV
#65	AnnotatorNotes T83	C1522726; Intravenous Route of Drug Administration; Functional Concept
T84	Neg_cue 1816 1830	a excepción de
T85	Neg_cue 1877 1888	ausencia de
T86	LIVB 1898 1907	Pacientes
#66	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	DEVI 1911 1926	silla de ruedas
#67	AnnotatorNotes T87	C0043143; wheelchair; Medical Device
T68	Age 732 769	entre 1 (12 en Rusia) y hasta 17 años
T88	PHYS 261 275	FARMACODINAMIA
#68	AnnotatorNotes T88	C0851347; Pharmacodynamics; Biologic Function
T89	LIVB 890 908	médico responsable
#69	AnnotatorNotes T89	C4708568; Medically responsible investigator; Professional or Occupational Group
T79	LIVB 1683 1701	médico responsable
#70	AnnotatorNotes T79	C4708568; Medically responsible investigator; Professional or Occupational Group
T90	Neg_cue 2026 2038	distintos de
T80	Neg_cue 1163 1175	diferentes a
A1	Population_data T62 Age
A2	Population_data T66 Age
A3	Population_data T74 Age
A4	Assertion T45 Negated
A5	Assertion T46 Negated
A6	Assertion T51 Negated
A7	Status T23 History_of
A8	Status T24 History_of
A9	Status T25 History_of
A10	Status T22 History_of
A11	Assertion T58 Negated
A12	Status T57 History_of
A13	Status T33 History_of
A14	Status T36 History_of
A15	Status T38 History_of
A16	Status T39 History_of
#71	AnnotatorNotes T82	C0521116; Current (present time); Temporal Concept 
#72	AnnotatorNotes T52	C0201734; Pharmacokinetic study; Research Activity + C1709518; Pharmacodynamic Study; Research Activity + C1705187; Safety Study; Research Activity
#73	AnnotatorNotes T38	C2362502; Safety Issues; Injury or Poisoning
#74	AnnotatorNotes T44	C1611640; Therapeutic agent (substance); Pharmacologic Substance 
#75	AnnotatorNotes T53	C0812152; Medication administration: subcutaneous; Therapeutic or Preventive Procedure 
A17	Assertion T71 Negated
R1	Has_Route_or_Mode Arg1:T1 Arg2:T61	
R2	Has_Route_or_Mode Arg1:T2 Arg2:T61	
R3	Experiences Arg1:T62 Arg2:T1	
R4	Experiences Arg1:T62 Arg2:T2	
R5	Experiences Arg1:T62 Arg2:T3	
R6	Has_Route_or_Mode Arg1:T5 Arg2:T64	
R7	Used_for Arg1:T5 Arg2:T53	
R8	Experiences Arg1:T65 Arg2:T63	
R9	Experiences Arg1:T65 Arg2:T88	
R10	Experiences Arg1:T65 Arg2:T6	
R11	Experiences Arg1:T66 Arg2:T7	
R12	Experiences Arg1:T66 Arg2:T8	
R13	Experiences Arg1:T66 Arg2:T9	
R15	Has_Frequency Arg1:T9 Arg2:T67	
R17	Experiences Arg1:T66 Arg2:T10	
R18	Experiences Arg1:T66 Arg2:T11	
R19	Experiences Arg1:T66 Arg2:T13	
R20	Experiences Arg1:T66 Arg2:T15	
R21	Location_of Arg1:T16 Arg2:T15	
R22	Location_of Arg1:T56 Arg2:T13	
R23	Location_of Arg1:T14 Arg2:T13	
R24	Location_of Arg1:T54 Arg2:T11	
R25	Location_of Arg1:T55 Arg2:T11	
R26	Location_of Arg1:T12 Arg2:T11	
R27	Overlap Arg1:T7 Arg2:T9	
R28	Overlap Arg1:T7 Arg2:T10	
R29	Overlap Arg1:T7 Arg2:T11	
R30	Overlap Arg1:T7 Arg2:T13	
R31	Overlap Arg1:T7 Arg2:T15	
R14	Overlap Arg1:T19 Arg2:T68	
T91	Observation 830 858	respuesta clínica inadecuada
#76	AnnotatorNotes T91	C0858218; Inappropriate drug response; Finding
#77	AnnotatorNotes T15	C4282165; Swollen Lymph Node; Sign or Symptom
R16	Overlap Arg1:T91 Arg2:T22	
R32	Overlap Arg1:T91 Arg2:T23	
R33	Used_for Arg1:T24 Arg2:T22	
R34	Used_for Arg1:T24 Arg2:T23	
R35	Used_for Arg1:T25 Arg2:T22	
R36	Used_for Arg1:T25 Arg2:T23	
R37	Used_for Arg1:T28 Arg2:T26	
R38	Used_for Arg1:T27 Arg2:T26	
R39	Used_for Arg1:T29 Arg2:T26	
R40	Used_for Arg1:T30 Arg2:T26	
R41	Has_Route_or_Mode Arg1:T30 Arg2:T69	
#78	AnnotatorNotes T27	C0242708; Antirheumatic Drugs, Disease-Modifying; Pharmacologic Substance
R42	Used_for Arg1:T57 Arg2:T31	
R43	Negation Arg1:T80 Arg2:T58	
R44	Has_Route_or_Mode Arg1:T58 Arg2:T71	
R45	Negation Arg1:T80 Arg2:T71	
R46	Has_Duration_or_Interval Arg1:T31 Arg2:T72	
R47	Has_Duration_or_Interval Arg1:T31 Arg2:T73	
R48	Before Arg1:T31 Arg2:T32	
R49	Used_for Arg1:T33 Arg2:T31	
R50	Has_Age Arg1:T74 Arg2:T75	
R51	Has_Age Arg1:T77 Arg2:T78	
R52	Experiences Arg1:T74 Arg2:T34	
R53	Experiences Arg1:T76 Arg2:T34	
R54	Experiences Arg1:T77 Arg2:T34	
R55	Used_for Arg1:T36 Arg2:T37	
R56	Has_Route_or_Mode Arg1:T36 Arg2:T81	
R57	Causes Arg1:T36 Arg2:T38	
R58	Causes Arg1:T36 Arg2:T39	
T92	Observation 1526 1554	respuesta clínica inadecuada
#79	AnnotatorNotes T92	C0858218; Inappropriate drug response; Finding
R59	Overlap Arg1:T36 Arg2:T92	
R60	Before Arg1:T92 Arg2:T37	
R61	Before Arg1:T38 Arg2:T37	
R62	Before Arg1:T39 Arg2:T37	
R63	Used_for Arg1:T59 Arg2:T42	
R64	Has_Route_or_Mode Arg1:T59 Arg2:T83	
R65	Overlap Arg1:T59 Arg2:T82	
T93	Quantifier_or_Qualifier 1637 1651	mal controlada
#80	AnnotatorNotes T93	C3853134; Poorly controlled; Functional Concept
R66	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T93	
T94	Quantifier_or_Qualifier 1766 1781	bien controlada
#81	AnnotatorNotes T94	C3853142; Well controlled; Functional Concept
R67	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T94	
R68	Negation Arg1:T84 Arg2:T45	
T95	CONC 1847 1855	JADAS-71
#82	AnnotatorNotes T95	C4053518; Juvenile Arthritis Disease Activity Score; Intellectual Product (?)
T96	Result_or_Value 1856 1873	menor o igual 3,8
R69	Has_Result_or_Value Arg1:T95 Arg2:T96	
R70	Negation Arg1:T85 Arg2:T46	
R71	Experiences Arg1:T86 Arg2:T47	
R72	Experiences Arg1:T86 Arg2:T87	
R73	Overlap Arg1:T95 Arg2:T46	
R74	Overlap Arg1:T43 Arg2:T46	
R75	Overlap Arg1:T40 Arg2:T46	
R76	Negation Arg1:T90 Arg2:T51	
R77	Overlap Arg1:T50 Arg2:T51	
R78	Overlap Arg1:T48 Arg2:T51	
R79	Overlap Arg1:T49 Arg2:T51	
R80	Experiences Arg1:T65 Arg2:T5	
A18	Experiencer T79 Other
A19	Experiencer T62 Patient
A20	Experiencer T65 Patient
A21	Experiencer T66 Patient
A22	Experiencer T89 Other
A23	Experiencer T70 Other
A24	Experiencer T74 Patient
A25	Experiencer T76 Patient
A26	Experiencer T77 Family_member
A27	Experiencer T86 Patient
A28	Status T91 History_of
